α-L-iduronidase therapy for mucopolysaccharidosis type I

References

• AggarwalSPittengerMF2005Human mesenchymal stem cells modulate allogeneic immune cell responsesBlood10518152215494428
   PubMed Web of Science ®Google Scholar
• BachGFriedmanRWeissmannB1972The defect in the Hurler and Scheie syndromes: deficiency of -L-iduronidaseProc Natl Acad Sci USA692048514262258
   PubMed Web of Science ®Google Scholar
• BaumCDullmannJLiZ2003Side effects of retroviral gene transfer into hematopoietic stem cellsBlood101209911412511419
   PubMed Web of Science ®Google Scholar
• BoelensJJWynnRFO’MearaA2007Outcomes of hematopoietic stem cell transplantation for Hurler’s syndrome in Europe: a risk factor analysis for graft failureBone Marrow Transplant402253317529997
   PubMed Web of Science ®Google Scholar
• BraunlinEMackey-BojackSPanoskaltsis-MortariA2006Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndromePediatr Res59273216326988
   PubMed Web of Science ®Google Scholar
• BraunlinEAStaufferNRPetersCH2003Usefulness of bone marrow transplantation in the Hurler syndromeAm J Cardiol92882614516901
   PubMed Web of Science ®Google Scholar
• ChungSMaXLiuY2007Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I miceMol Genet Metab901819216979922
   PubMed Web of Science ®Google Scholar
• ClarkeLARussellCSPownallS1997Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase geneHum Mol Genet6503119097952
   PubMed Web of Science ®Google Scholar
• ComanDJHayesIMCollinsV2008Enzyme replacement therapy for mucopolysaccharidoses: opinions of patients and familiesJ Pediatr152723718410781
   PubMed Web of Science ®Google Scholar
• Cox-BrinkmanJBoelensJJWraithJE2006Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndromeBone Marrow Transplant38172116715104
   PubMed Web of Science ®Google Scholar
• DangelJH1998Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders–clinical and echocardiographic findings in 64 patientsEur J Pediatr15753489686810
   PubMed Web of Science ®Google Scholar
• Di DomenicoCVillaniGRDi NapoliD2005Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vectorHum Gene Ther16819015703491
   PubMed Web of Science ®Google Scholar
• DicksonPMcEnteeMVoglerC2007Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluidMol Genet Metab9161817321776
   PubMed Web of Science ®Google Scholar
• EllinwoodNMViteCHHaskinsME2004Gene therapy for lysosomal storage diseases: the lessons and promise of animal modelsJ Gene Med648150615133760
   PubMed Web of Science ®Google Scholar
• FieldREBuchananJACopplemansMG1994Bone-marrow transplantation in Hurler’s syndrome. Effect on skeletal developmentJ Bone Joint Surg Br76975817983131
   PubMedGoogle Scholar
• FischerAAbinaSHThrasherA2004LMO2 and gene therapy for severe combined immunodeficiencyN Engl J Med35025267author reply 2526–715190153
   PubMed Web of Science ®Google Scholar
• FischerHDGonzalez-NoriegaASlyWS1980Phosphomannosylenzyme receptors in rat liver. Subcellular distribution and role in intracellular transport of lysosomal enzymesJ Biol Chem2559608156253448
   PubMed Web of Science ®Google Scholar
• FratantoniJCHallCWNeufeldEF1968aThe defect in Hurler’s and Hunter’s syndromes: faulty degradation of mucopolysaccharideProc Natl Acad Sci USA606997064236091
   PubMed Web of Science ®Google Scholar
• FratantoniJCHallCWNeufeldEF1968bHurler and Hunter syndromes: mutual correction of the defect in cultured fibroblastsScience16257024236721
   PubMed Web of Science ®Google Scholar
• GassasASungLDoyleJJ2003Life-threatening pulmonary hemorrhages post bone marrow transplantation in Hurler syndrome. Report of three cases and review of the literatureBone Marrow Transplant32213512838287
   PubMed Web of Science ®Google Scholar
• GlarosENTurnerCTParkinsonEJ2002Immune response to enzyme replacement therapy: single epitope control of antigen distribution from circulationMol Genet Metab771273512359140
   PubMed Web of Science ®Google Scholar
• GrewalSSKrivitWDeforTE2002Outcome of second hematopoietic cell transplantation in Hurler syndromeBone Marrow Transplant29491611960268
   PubMed Web of Science ®Google Scholar
• GrewalSSWynnRAbdenurJE2005Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndromeGenet Med7143615714083
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-AbinaSVon KalleCSchmidtM2003aA serious adverse event after successful gene therapy for X-linked severe combined immunodeficiencyN Engl J Med348255612529469
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-AbinaSVon KalleCSchmidtM2003bLMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1Science302415914564000
   PubMed Web of Science ®Google Scholar
• HansenMDFilipovichAHDaviesSM2008Allogeneic hematopoietic cell transplantation (HCT) in Hurler’s syndrome using a reduced intensity preparative regimenBone Marrow Transplant413495318026148
   PubMed Web of Science ®Google Scholar
• HartungSDFrandsenJLPanD2004Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase geneMol Ther98667515194053
   PubMed Web of Science ®Google Scholar
• HasilikANeufeldEF1980Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residuesJ Biol Chem2554946506989822
   PubMed Web of Science ®Google Scholar
• HirthABergAGreveG2007Successful treatment of severe heart failure in an infant with Hurler syndromeJ Inherit Metab Dis3082017768668
   PubMed Web of Science ®Google Scholar
• HobbsJRHugh-JonesKBarrettAJ1981Reversal of clinical features of Hurler’s disease and biochemical improvement after treatment by bone-marrow transplantationLancet2709126116856
   PubMed Web of Science ®Google Scholar
• KakavanosRTurnerCTHopwoodJJ2003Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis ILancet36116081312747881
   PubMed Web of Science ®Google Scholar
• KakkisELesterTYangR2004aSuccessful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis IProc Natl Acad Sci USA1018293414715900
   PubMed Web of Science ®Google Scholar
• KakkisEMcEnteeMVoglerC2004bIntrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS IMol Genet Metab831637415464431
   PubMed Web of Science ®Google Scholar
• KakkisEDMatyniaAJonasAJ1994Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cellsProtein Expr Purif5225327950365
   PubMed Web of Science ®Google Scholar
• KakkisEDMcEnteeMFSchmidtchenA1996Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis IBiochem Mol Med58156678812735
   PubMedGoogle Scholar
• KakkisEDMuenzerJTillerGE2001aEnzyme-replacement therapy in mucopolysaccharidosis IN Engl J Med344182811172140
   PubMed Web of Science ®Google Scholar
• KakkisEDSchuchmanEHeX2001bEnzyme replacement therapy in feline mucopolysaccharidosis IMol Genet Metab7219920811243725
   PubMed Web of Science ®Google Scholar
• KaufmanHHRosenbergHSScottCI1982Cervical myelopathy due to dural compression in mucopolysaccharidosisSurg Neurol17404106810485
   PubMedGoogle Scholar
• KennedyDWAbkowitzJL1997Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation modelBlood90986939242527
   PubMed Web of Science ®Google Scholar
• KennedyPSwashMDeanMF1973Cervical cord compression in mucopolysaccharidosisDev Med Child Neurol1519494266829
   PubMed Web of Science ®Google Scholar
• KhannaGVan HeestAEAgelJ2007Analysis of factors affecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantationBone Marrow Transplant39331417277793
   PubMed Web of Science ®Google Scholar
• KobayashiHCarbonaroDPepperK2005Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vectorMol Ther117768915851016
   PubMed Web of Science ®Google Scholar
• KocONDayJNiederM2002Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)Bone Marrow Transplant302152212203137
   PubMed Web of Science ®Google Scholar
• KrivitWPetersCShapiroEG1999Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type IIICurr Opin Neurol121677610226749
   PubMed Web of Science ®Google Scholar
• KrivitWSungJHShapiroEG1995Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseasesCell Transplant4385927582569
   PubMed Web of Science ®Google Scholar
• KunterURongSDjuricZ2006Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritisJ Am Soc Nephrol1720212
   Web of Science ®Google Scholar
• Le BlancKRasmussonISundbergB2004Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cellsLancet3634394114962524
   PubMed Web of Science ®Google Scholar
• Le BlancKRingdenO2005aImmunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantationBiol Blood Marrow Transplant112134
   PubMed Web of Science ®Google Scholar
• Le BlancKRingdenO2005bUse of mesenchymal stem cells for the prevention of immune complications of hematopoietic stem cell transplantationHaematologica9038a
   PubMedGoogle Scholar
• Lee-ChenGJLinSPTangYF1999Mucopolysaccharidosis type I: characterization of novel mutations affecting alpha-L-iduronidase activityClin Genet56667010466419
   PubMed Web of Science ®Google Scholar
• Lee-ChenGJWangTR1997Mucopolysaccharidosis type I: identification of novel mutations that cause Hurler/Scheie syndrome in Chinese familiesJ Med Genet3439419032648
   PubMed Web of Science ®Google Scholar
• LiuYXuLHennigAK2005Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I miceMol Ther11354715585404
   PubMed Web of Science ®Google Scholar
• LutzkoCOmoriFAbrams-OggAC1999Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of diseaseHum Gene Ther1052132
   Web of Science ®Google Scholar
• MaXLiuYTittigerM2007Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulationMol Ther1588990217311010
   PubMed Web of Science ®Google Scholar
• MastersonELMurphyPGO’MearaA1996Hip dysplasia in Hurler’s syndrome: orthopaedic management after bone marrow transplantationJ Pediatr Orthop16313
   Web of Science ®Google Scholar
• McCormackMPForsterADrynanL2003The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell developmentMol Cell Biol2390031314645513
   PubMed Web of Science ®Google Scholar
• MeiklePJHopwoodJJClagueAE1999Prevalence of lysosomal storage disordersJAMA2814954
   Web of Science ®Google Scholar
• MullerIKustermann-KuhnBHolzwarthC2006In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patientsExp Hematol344139
   Web of Science ®Google Scholar
• NeufeldEF1991Lysosomal storage diseasesAnnu Rev Biochem605780
   Web of Science ®Google Scholar
• OdunusiEPetersCKrivitW1999Genu valgum deformity in Hurler syndrome after hematopoietic stem cell transplantation: correction by surgical interventionJ Pediatr Orthop197049890291
   PubMed Web of Science ®Google Scholar
• OestreichAE1985The stylohyoid ligament in Hurler syndrome and related conditions: comparison with normal childrenRadiology15466563918332
   PubMed Web of Science ®Google Scholar
• OhmiKGreenbergDSRajavelKS2003Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIBProc Natl Acad Sci USA1001902712576554
   PubMed Web of Science ®Google Scholar
• OrchardPJBlazarBRWagnerJ2007Hematopoietic cell therapy for metabolic diseaseJ Pediatr151340617889065
   PubMed Web of Science ®Google Scholar
• OsbornMJMcElmurryRTPeacockB2008Targeting of the CNS in MPS-IH Using a Nonviral Transferrin-alpha-L-iduronidase Fusion Gene ProductMol TherIn press
   Web of Science ®Google Scholar
• PardridgeWM2005aThe blood-brain barrier and neurotherapeuticsNeuroRx21215717052
   PubMedGoogle Scholar
• PardridgeWM2005bThe blood-brain barrier: bottleneck in brain drug developmentNeuroRx231415717053
   PubMedGoogle Scholar
• PardridgeWM2005cMolecular biology of the blood-brain barrierMol Biotechnol30577015805577
   PubMed Web of Science ®Google Scholar
• PastoresGMArnPBeckM2007The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type IMol Genet Metab91374717336562
   PubMed Web of Science ®Google Scholar
• PetersCBalthazorMShapiroEG1996Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndromeBlood8748949028639864
   PubMed Web of Science ®Google Scholar
• PetersCShapiroEGAndersonJ1998aHurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study GroupBlood91260189516162
   PubMed Web of Science ®Google Scholar
• PetersCShapiroEGKrivitW1998bHurler syndrome: past, present, and futureJ Pediatr133799672503
   PubMed Web of Science ®Google Scholar
• PetersCShapiroEGKrivitW1998cNeuropsychological development in children with Hurler syndrome following hematopoietic stem cell transplantationPediatr Transplant2250310084724
   PubMedGoogle Scholar
• PolgreenLETolarJPlogM2008Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantationBone Marrow Transplant4110051118278070
   PubMed Web of Science ®Google Scholar
• PonderKPHaskinsME2007Gene therapy for mucopolysaccharidosisExpert Opin Biol Ther713334517727324
   PubMed Web of Science ®Google Scholar
• PorteusMHConnellyJPPruettSM2006A look to future directions in gene therapy research for monogenic diseasesPLoS Genet2e13317009872
   PubMed Web of Science ®Google Scholar
• ProckopDJ2007“Stemness” does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs)”Clin Pharmacol Ther82241317700588
   PubMed Web of Science ®Google Scholar
• ProckopDJOlsonSD2007Clinical trials with adult stem/progenitor cells for tissue repair: let’s not overlook some essential precautionsBlood10931475117170129
   PubMed Web of Science ®Google Scholar
• RempelBPClarkeLAWithersSG2005A homology model for human alpha-l-iduronidase: insights into human diseaseMol Genet Metab85283715862278
   PubMed Web of Science ®Google Scholar
• RenteriaVGFerransVJRobertsWC1976The heart in the Hurler syndrome: gross, histologic and ultrastructural observations in five necropsy casesAm J Cardiol38487501823811
   PubMed Web of Science ®Google Scholar
• RoubicekMGehlerJSprangerJ1985The clinical spectrum of alpha-L-iduronidase deficiencyAm J Med Genet20471813922223
   PubMed Web of Science ®Google Scholar
• RussellCHendsonGJevonG1998Murine MPS I: insights into the pathogenesis of Hurler syndromeClin Genet53349619660052
   PubMed Web of Science ®Google Scholar
• SchmidtHUllrichKVon LengerkeHJ1987Radiological findings in patients with mucopolysaccharidosis I H/S (Hurler-Scheie syndrome)Pediatr Radiol17409143114705
   PubMed Web of Science ®Google Scholar
• SchuchmanEHGuzmanNADesnickRJ1984Human alpha-L-iduronidase. I. Purification and properties of the high uptake (higher molecular weight) and the low uptake (processed) formsJ Biol Chem2593132406421818
   PubMed Web of Science ®Google Scholar
• ScottHSBungeSGalA1995Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implicationsHum Mutat62883028680403
   PubMed Web of Science ®Google Scholar
• ScottHSLitjensTNelsonPV1992alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotypeHum Mutat133391301941
   PubMedGoogle Scholar
• ScottHSLitjensTNelsonPV1993Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromesAm J Hum Genet53973868213840
   PubMed Web of Science ®Google Scholar
• ShapiroEGLockmanLABalthazorM1995Neuropsychological outcomes of several storage diseases with and without bone marrow transplantationJ Inherit Metab Dis18413297494400
   PubMed Web of Science ®Google Scholar
• ShullRLuXDubeI1996Humoral immune response limits gene therapy in anine MPS IBlood8837798704199
   PubMed Web of Science ®Google Scholar
• ShullRMKakkisEDMcEnteeMF1994Enzyme replacement in a canine model of Hurler syndromeProc Natl Acad Sci USA9112937417809150
   PubMed Web of Science ®Google Scholar
• SifuentesMDoroshowRHoftR2007A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 yearsMol Genet Metab901718017011223
   PubMed Web of Science ®Google Scholar
• SouilletGGuffonNMaireI2003Outcome of 27 patients with Hurler’s syndrome transplanted from either related or unrelated haematopoietic stem cell sourcesBone Marrow Transplant3111051712796790
   PubMed Web of Science ®Google Scholar
• StabaSLEscolarMLPoeM2004Cord-blood transplants from unrelated donors in patients with Hurler’s syndromeN Engl J Med3501960915128896
   PubMed Web of Science ®Google Scholar
• SugawaraKSaitoSOhnoK2008Structural study on mutant alpha-L-iduronidases: insight into mucopolysaccharidosis type IJ Hum Genet534677418340403
   PubMed Web of Science ®Google Scholar
• TaylorCBradyPO’MearaA2008Mobility in Hurler syndromeJ Pediatr Orthop28163818388709
   PubMed Web of Science ®Google Scholar
• TaylorKRGalloRL2006Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammationFaseb J2092216394262
   PubMed Web of Science ®Google Scholar
• TolarJGrewalSSBjorakerKJ2007Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndromeBone Marrow TransplantIn press
   Google Scholar
• TolarJOrchardPJKeyNS2008Circulating anticoagulant glycosaminoglycans in mucopolysaccharidosis type IJ Thromb Haemost6893518315551
   PubMed Web of Science ®Google Scholar
• TraasAMWangPMaX2007Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapyMol Ther1514233117519893
   PubMed Web of Science ®Google Scholar
• TurnerCTHopwoodJJBrooksDA2000Enzyme replacement therapy in mucopolysaccharidosis I: altered distribution and targeting of alpha-L-iduronidase in immunized ratsMol Genet Metab692778510870845
   PubMed Web of Science ®Google Scholar
• UngerEGDurrantJAnsonDS1994Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblastsBiochem J3044397998955
   PubMed Web of Science ®Google Scholar
• VellodiAYoungEPCooperA1997Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centresArch Dis Child769299068295
   PubMed Web of Science ®Google Scholar
• VinallongaXSanzNBalaguerA1992Hypertrophic cardiomyopathy in mucopolysaccharidoses: regression after bone marrow transplantationPediatr Cardiol1310791614914
   PubMed Web of Science ®Google Scholar
• Von KalleCFehseBLayh-SchmittG2004Stem cell clonality and genotoxicity in hematopoietic cells: gene activation side effects should be avoidableSemin Hematol413031815508116
   PubMed Web of Science ®Google Scholar
• WatsonGBastackyJBelichenkoP2006Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I miceGene Ther139172516482204
   PubMed Web of Science ®Google Scholar
• WeissteinJSDelgadoESteinbachLS2004Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantationJ Pediatr Orthop249710114676543
   PubMed Web of Science ®Google Scholar
• WraithJE2001Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficultiesJ Inherit Metab Dis242455011405343
   PubMed Web of Science ®Google Scholar
• WraithJEBeckMLaneR2007Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)Pediatrics120e374617606547
   PubMed Web of Science ®Google Scholar
• WraithJEClarkeLABeckM2004Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)J Pediatr144581815126990
   PubMed Web of Science ®Google Scholar
• ZhengYRozengurtNRyazantsevS2003Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrowMol Genet Metab792334412948739
   PubMed Web of Science ®Google Scholar